Equity Details
Price & Market Data
Price: $0.504
Daily Change: -$0.0061 / 1.21%
Daily Range: $0.491 - $0.53
Market Cap: $17,622,708
Daily Volume: 645,096
Performance Metrics
1 Week: -14.98%
1 Month: -13.54%
3 Months: 14.99%
6 Months: -15.78%
1 Year: -56.40%
YTD: -11.79%
About OSR Holdings, Inc. (OSRH)
Market summary for OSR Holdings, Inc. (OSRH). Price: 0.504, daily change: -$0.0061 / 1.21%. Market cap: 17,622,708. Performance YTD, 1-month, 3-month.
Company Details
Employees: 22
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Germany, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.